Gender-Affirming Medications Among Transgender Adolescents in the US, 2018-2022

JAMA Pediatr. 2025 Jan 6. doi: 10.1001/jamapediatrics.2024.6081. Online ahead of print.
No abstract available

Plain language summary

This cross-sectional study explores the receipt of gender-affirming medications among transgender and gender-diverse adolescents in the US, analyzing these rates by age and sex assigned at birth.